Stay up-to-date with the most recent news stories from around the world
Total: 5094
Amoy Diagnostics has received NMPA approval for its c-Met gene amplification kit, a companion diagnostic for the lung cancer drug Savolitinib. This development marks a vital step in China's push for localized precision oncology and sophisticated personalized medicine tools.
Xiaomi founder Lei Jun has announced a massive AI recruitment initiative backed by a 16-billion-yuan R&D budget for 2026. The move aims to accelerate Xiaomi’s progress in foundation models and embodied robotics, solidifying its transition into an AI-driven conglomerate.
Huatai Baoxing Fund is facing intense criticism for blocking institutional redemptions and allegedly inflating 'mini-fund' returns through penalty fee loopholes. These controversial tactics underscore the desperation of underperforming Chinese fund managers to retain capital and manipulate performance rankings to attract retail investors.
Tencent is aggressively doubling down on the OpenClaw AI agent framework to counter its lag in foundational model development. By flooding the WeChat ecosystem with open-source-based applications, the tech giant aims to dominate the AI service layer despite cooling market enthusiasm and significant structural dependencies.
Beijing has launched China's first regulated commercial insurance framework for intelligent vehicles, addressing the liability gap for L2 to L4 autonomous driving. The initiative replaces informal automaker promises with formal actuarial products, aiming to boost consumer confidence in self-driving technologies.
China's SAMR has issued a major directive to implement the 2025 Anti-Unfair Competition Law, targeting 'involution' in the EV and battery sectors while tightening control over platform algorithms. The law introduces extraterritorial reach and new protections for SMEs against payment arrears by large corporations.
Ping An Insurance has achieved a historic 1 trillion RMB net asset milestone, driven by a 10.3% growth in operating profit and a strategic pivot toward bancassurance. The company is successfully capturing maturing household deposits as Chinese savers shift away from traditional bank accounts in search of stable yields.
Beijing has launched a pilot commercial insurance program for intelligent connected vehicles, aiming to resolve the legal and financial uncertainties surrounding autonomous driving. By providing a regulated framework for L2 to L4 systems, the move addresses consumer anxiety and sets a national precedent for the commercialization of self-driving technology.
The Shanghai Composite Index staged a late-day recovery to close up 0.24% despite global market volatility, driven by a surge in commercial space and aluminum stocks. High trading volumes indicate a strategic rotation into policy-supported industrial sectors as investors navigate geopolitical uncertainties.
Major shareholders of Longfor Group have donated 100 million shares to an employee trust to incentivize core talent during the real estate industry's downturn. This move, valued at roughly HK$740 million, highlights a strategic commitment to long-term stability and internal alignment as the company navigates China's challenging property market.
China is set to test its first 7-ton large-scale transport drone, the Changying-8, at Zhengzhou Shangjie Airport. This 'unmanned heavy truck' aims to revolutionize logistics by validating AI-driven flight controls and high-capacity autonomous transport capabilities.
DeepSeek has restored its web and app services after a major overnight outage that sparked concerns over its infrastructure capacity. The disruption occurred amid high anticipation for the upcoming V4 model, highlighting the operational challenges facing China's leading AI contender.
Meituan has successfully defended its market dominance in China’s food delivery sector despite a collective industry subsidy spend of 150 billion RMB in 2025. The company is now pivoting toward AI-driven logistics and global expansion as Chinese regulators signal an end to irrational price competition.
Surging global oil prices are causing a 'butterfly effect' across China's economy, raising costs for agriculture, logistics, and manufacturing. The impact is moving beyond the pump to affect petrochemical-dependent goods like plastics, synthetic clothing, and even electric vehicle components.
The Li Ka-shing family has emerged as a global energy titan, with their controlled oil production reaching one million barrels per day following the acquisition of MEG Energy. This 40-year investment journey, starting with the 1986 purchase of Husky Energy, demonstrates a masterful use of contrarian investing to build a massive 'hard asset' hedge against global economic volatility.
Aux Electrical, once the dominant low-cost disruptor in China’s air conditioning market, is facing a severe profit crunch as its 'Price Butcher' strategy fails to combat rising raw material costs and technological stagnation. Despite a 2025 IPO, the company’s reliance on low-margin ODM sales and a lack of R&D investment has left it vulnerable to more integrated competitors like Xiaomi and Midea.
China has officially surpassed Japan as the world's leading automotive seller in 2025, ending a 25-year streak of Japanese dominance. While Chinese brands like BYD and Geely lead in volume and EV innovation, they still face significant challenges regarding profit margins and access to the North American market.
China's 'bloom economy' is evolving from simple sightseeing into a sophisticated multi-billion dollar industry that integrates technology, sports, and corporate investment. Local governments are increasingly using seasonal floral displays as strategic 'soft power' tools to build urban brands and attract high-value industrial projects.
A sophisticated theft of 12 tons of F1-themed KitKat bars traveling from Italy to Poland has disrupted Nestlé’s supply chain ahead of the Easter holiday. The incident underscores a rising trend of complex cargo fraud in Europe, targeting high-value brand collaborations during peak demand seasons.
Haier Group has issued a formal denial regarding any involvement in controversial 'blood-replacement' therapies or partnerships with entrepreneur Yu Wenhong. The conglomerate is pursuing legal action to protect its healthcare brand, Yingkang Life, from reputational damage caused by fringe medical claims.
